Latest News about FDA
Recent news which mentions FDA
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
Today 14:11 EDT
From Benzinga
FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients
March 31, 2025
From Benzinga
FDA Approves Sanofi's Hemophilia Drug
March 31, 2025
From Benzinga
RFK Jr. Spreading 'Misinformation and Lies'? FDA's Top Vaccine Official Walks Out, Sparking Debate on Safety and Public Trust
March 29, 2025
Tickers
NEWS
From Benzinga
From Benzinga
Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder
March 27, 2025
From Benzinga
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors
March 26, 2025
From Benzinga
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
March 26, 2025
From Benzinga
Tenon Stock Soars After FDA Clears Catamaran SI Fusion
March 25, 2025
From Wall Street Pit
From Benzinga
FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease
March 21, 2025
From Benzinga
Alnylam's Amvuttra Secures FDA Approval For Expanded Use For Rare Heart Disease, Stock Jumps
March 21, 2025
From Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
March 21, 2025
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.